Doxorubicin Cardiomyopathy
Doxorubicin Cardiomyopathy
About this item
Full title
Doxorubicin Cardiomyopathy
Author / Creator
Publisher
Basel, Switzerland: S. Karger AG
Journal title
Cardiology, 2010-01, Vol.115 (2), p.155-162
Language
English
Formats
Publication information
Publisher
Basel, Switzerland: S. Karger AG
Subjects
More information
Scope and Contents
Contents
Established doxorubicin cardiomyopathy is a lethal disease. When congestive heart failure develops, mortality is approximately 50%. Extensive research has been done to understand the mechanism and pathophysiology of doxorubicin cardiomyopathy, and considerable knowledge and experience has been gained. Unfortunately, no effective treatment for estab...
Alternative Titles
Full title
Doxorubicin Cardiomyopathy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_karger_primary_265166
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_karger_primary_265166
Other Identifiers
ISSN
0008-6312
E-ISSN
1421-9751
DOI
10.1159/000265166
